Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of the Iron Chelator Deferiprone in Parkinson's Disease (FAIR-PARK-I)

This study has been completed.
Information provided by (Responsible Party):
University Hospital, Lille Identifier:
First received: July 20, 2009
Last updated: August 31, 2012
Last verified: July 2009